Former Celgene CEO Bob Hugin loses in US midterm elections
November 7, 2018Research and Development Bob Hugin, Celgene, Trump, midterms, republican, us politics
Former Celgene CEO Bob Hugin has failed in his bid to win over the people of New Jersey, after voters …
FDA approves BMS’ multiple myeloma combo after it doubles progression-free survival
November 7, 2018Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Empliciti, FDA, US, multiple myeloma, pharma
The FDA has seen fit to approve Bristol-Myers Squibb’s Empliciti (elotuzumab) intravenous injection in combination with pomalidomide and dexamethasone for …
Lilly’s Trulicity reduces major cardiovascular events in “ambitious” trial of type 2 diabetes
November 7, 2018Research and Development Eli Lilly, Trulicity, cardiovascular events, pharma, type 2 diabetes
Eli Lilly has revealed new data on Trulicity (dulaglutide), showing that glucagon-like peptide-1 (GLP-1) receptor agonist achieved its primary endpoint …
Very high concentrations of pharmaceuticals found in animals in Australian streams
November 7, 2018Research and Development Contamination, ecosystems, environment, pharmaceuticals, pollution
More than 60 different pharmaceutical compounds were detected in aquatic invertebrate larvae and riparian predators in six streams near Melbourne, …
UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres
November 6, 2018Manufacturing and Production, Research and Development AI, Leeds, London, Oxford, UK, glasgow, pharma
The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced …
Clearside Biomedical shares plummet by 56% after disappointing Phase 3 results
November 6, 2018Manufacturing and Production
Shares in the US-based pharma firm Clearside Biomedical plummeted on Monday after the company announced disappointing phase III trial results …
Health Secretary launches new prevention strategy for NHS
November 6, 2018Manufacturing and Production Matt Hancock, NHS, health, prevention
British Health Secretary Matt Hancock has said that healthcare should focus on prevention, as he launched a long-term strategy intended …
AstraZeneca sells off three drugs in deal worth $350 million
November 6, 2018Manufacturing and Production AstraZeneca, asthma, covis, deal, royalties
Anglo-Swedish multinational AstraZeneca has agreed to sell the rights to three asthma and rhinitis drugs in a deal worth $350 …
J&J buy global rights to Yuhan’s lazertinib in deal worth $1.2bn
November 6, 2018Manufacturing and Production J&J, JJ, NSCLC, Yuhan, deal, lazertinib, south korea
Johnson & Johnson’s Janssen Biotech unit has bought the rights to Yuhan’s third-generation EGFR tyrosine kinase inhibitor (TKI) lazertinib in a deal …
The November 2018 issue of Pharmafocus is available to read online now!
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, President trump, Trump, anti vaxxer, brexit, clinical trials, opioid crisis, opioids, pharma, vaccines
As the US continues to battle the demons in its healthcare system, Donald Trump looks like he may finally make …
Anti-vaxxers: Vaccines in the age of populism
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing anti vaccine, anti-vaccine, history, medicine, populism, vaccines
Mistrust of the establishment has fuelled anti-vaccine sentiment in recent years, and adherence has waned as a result. Louis Goss …
FDA controversially approves potent opioid up to ten times stronger than fentanyl
November 6, 2018Sales and Marketing Dsuvia, FDA, US, fentanyl, opioid crisis, opioids, pharma
Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five …
Aurobindo pharma initiate recall of blood pressure drug Ibesartan
November 6, 2018Manufacturing and Production, Research and Development Aurobindo Pharma, FDA, heart drug, ibesartan, recall
Indian pharma firm Aurobindo Pharma Ltd has initiated a voluntary recall of 22 batches of blood pressure drug Ibesartan, due …
76% of patients no longer experience PTSD a year after MDMA-assisted psychotherapy
November 6, 2018Manufacturing and Production, Research and Development MDMA, PTSD, mental health, psychotherapy, research
Promising phase II results suggest that MDMA-assisted psychotherapy may be an “innovative, efficacious treatment for posttraumatic stress disorder,” according to …
HIV drug reduces viral load by 99% within 4 weeks
November 6, 2018Manufacturing and Production, Research and Development
HIV-drug Gammora may eliminate 99% of the HIV virus within four weeks of treatment, according to the results of a …
GSK’s anti-seizure drug shows promise in early depression study
November 2, 2018Medical Communications, Research and Development GSK, GlaxoSmithKline, Potiga, depression, pharma
Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications …
Top Ten most popular articles on Pharmafile.com this week!
November 2, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, ITH Pharma, J&J, JJ, NICE, Sanofi, Trump, top 10
Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …
Committee advises against FDA approval of Alkermes’ novel depression drug
November 2, 2018Medical Communications, Sales and Marketing Alkermes, FDA, depression, pharma
Alkermes has been knocked back with the disappointing, though not entirely unexpected, news that the FDA-appointed Psychopharmacologic Drugs Advisory Committee …
Novo Nordisk cuts 1300 jobs in the midst of Trump’s pricing pressures and depreciation of US dollar
November 2, 2018Medical Communications Jobs, Novo Nordisk, Trump, pressure, pricing, revenue
Danish multinational Novo Nordisk has said that they will have cut 1,300 employees by the end of 2018. The decision …
GW Pharma’s Epidiolex becomes first cannabis-based medicine to be made available in United States
November 2, 2018Medical Communications Epidiolex, GW Pharma, Medical marijuana, cannabidiol, cannabis
GW Pharma’s Epidiolex has become the first plant-derived, cannabis-based medicine to be made available on prescription in all 50 US …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
